(19)
(11) EP 4 240 394 A2

(12)

(88) Date of publication A3:
14.07.2022

(43) Date of publication:
13.09.2023 Bulletin 2023/37

(21) Application number: 21890074.4

(22) Date of filing: 04.11.2021
(51) International Patent Classification (IPC): 
A61K 38/10(2006.01)
A61P 37/04(2006.01)
C07K 7/08(2006.01)
(52) Cooperative Patent Classification (CPC):
C07K 14/7155; C07K 14/55
(86) International application number:
PCT/US2021/058085
(87) International publication number:
WO 2022/098890 (12.05.2022 Gazette 2022/19)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 04.11.2020 US 202017089515

(60) Divisional application:
23187951.1

(71) Applicant: Medikine, Inc.
Menlo Park CA 94025 (US)

(72) Inventors:
  • DOWER, William J.
    Menlo Park, CA 94025 (US)
  • NEEDELS, Michael C.
    Menlo Park, CA 94025 (US)
  • BARRETT, Ronald W.
    Menlo Park, CA 94025 (US)
  • BAKKER, Alice V.
    Menlo Park, CA 94025 (US)
  • CWIRLA, Steven E.
    Menlo Park, CA 94025 (US)

(74) Representative: Marks & Clerk LLP 
15 Fetter Lane
London EC4A 1BW
London EC4A 1BW (GB)

   


(54) IL-2R BETA-GAMMA C BINDING COMPOUNDS AND USES THEREOF